Changwon-si, South Korea

Yeon-Jeong Kim



Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yeon-Jeong Kim: Innovator in Immuno-Therapeutic Vaccines

Introduction

Yeon-Jeong Kim is a prominent inventor based in Changwon-si, South Korea. He has made significant contributions to the field of immunotherapy, particularly in the development of vaccines aimed at treating infectious diseases and cancer. With a total of 2 patents, his work is paving the way for innovative therapeutic solutions.

Latest Patents

Kim's latest patents include a vaccine comprising monocyte or immature myeloid cells (IMC) loaded with the ligand of natural killer T cells and an antigen. This immuno-therapeutic and prophylactic vaccine is designed for the prevention and treatment of infectious diseases or cancer. The invention utilizes monocytes or IMCs, which are more easily obtainable than dendritic cells, to induce significant cytotoxic T lymphocyte responses and provide therapeutic effects on malignant tumors.

Another notable patent is a B cell-based vaccine loaded with the ligand of natural killer T cells and an antigen. This vaccine is also aimed at preventing and treating diseases, specifically as an antitumor immunotherapeutic agent. The B cells used in this vaccine are similarly accessible compared to dendritic cells and can induce comparable cytotoxic T lymphocyte responses, offering both prophylactic and therapeutic effects on solid and metastatic tumors.

Career Highlights

Throughout his career, Yeon-Jeong Kim has worked with notable organizations such as Cellid Co., Ltd. and Seoul National University. His experience in these institutions has contributed to his expertise in vaccine development and immunotherapy.

Collaborations

Some of his notable coworkers include Chang-Yuil Kang and Hyun-Jeong Ko. Their collaborative efforts have further advanced the research and development of innovative vaccine technologies.

Conclusion

Yeon-Jeong Kim's contributions to the field of immunotherapy through his patents and collaborations highlight his role as a key innovator in vaccine development. His work continues to inspire advancements in the treatment of infectious diseases and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…